Cargando…
PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP
PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310027/ https://www.ncbi.nlm.nih.gov/pubmed/32572592 http://dx.doi.org/10.1186/s13550-020-00657-7 |
_version_ | 1783549289374416896 |
---|---|
author | Du, Yong Minn, Il Foss, Catherine Lesniak, Wojciech G. Hu, Feng Dannals, Robert F. Pomper, Martin G. Horti, Andrew G. |
author_facet | Du, Yong Minn, Il Foss, Catherine Lesniak, Wojciech G. Hu, Feng Dannals, Robert F. Pomper, Martin G. Horti, Andrew G. |
author_sort | Du, Yong |
collection | PubMed |
description | PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of epoxyeicosatrienoic acids (EETs) and play an important role in neurovascular coupling. [(18)F]FNDP, a PET radiotracer for imaging sEH, was evaluated through quantitative PET imaging in the baboon brain, radiometabolite analysis, and radiation dosimetry estimate. METHODS: Baboon [(18)F]FNDP dynamic PET studies were performed at baseline and with blocking doses of the selective sEH inhibitor AR-9281 to evaluate sEH binding specificity. Radiometabolites of [(18)F]FNDP in mice and baboons were measured by high-performance liquid chromatography. Regional brain distribution volume (V(T)) of [(18)F]FNDP was computed from PET using radiometabolite-corrected arterial input functions. Full body distribution of [(18)F]FNDP was studied in CD-1 mice, and the human effective dose was estimated using OLINDA/EXM software. RESULTS: [(18)F]FNDP exhibited high and rapid brain uptake in baboons. AR-9281 blocked [(18)F]FNDP uptake dose-dependently with a baseline V(T) of 10.9 ± 2.4 mL/mL and a high-dose blocking V(T) of 1.0 ± 0.09 mL/mL, indicating substantial binding specificity (91.70 ± 1.74%). The V(ND) was estimated as 0.865 ± 0.066 mL/mL. The estimated occupancy values of AR-9281 were 99.2 ± 1.1% for 1 mg/kg, 88.6 ± 1.3% for 0.1 mg/kg, and 33.8 ± 3.8% for 0.02 mg/kg. Murine biodistribution of [(18)F]FNDP enabled an effective dose estimate for humans (0.032 mSv/MBq). [(18)F]FNDP forms hydrophilic radiometabolites in murine and non-human primate plasma. However, only minute amounts of the radiometabolites entered the animal brain (< 2% in mice). CONCLUSIONS: [(18)F]FNDP is a highly sEH-specific radiotracer that is suitable for quantitative PET imaging in the baboon brain. [(18)F]FNDP holds promise for translation to human subjects. |
format | Online Article Text |
id | pubmed-7310027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73100272020-06-24 PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP Du, Yong Minn, Il Foss, Catherine Lesniak, Wojciech G. Hu, Feng Dannals, Robert F. Pomper, Martin G. Horti, Andrew G. EJNMMI Res Original Research PURPOSE: Soluble epoxide hydrolase (sEH) is a promising candidate positron emission tomography (PET) imaging biomarker altered in various disorders, including vascular cognitive impairment (VCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and depression, known to regulate levels of epoxyeicosatrienoic acids (EETs) and play an important role in neurovascular coupling. [(18)F]FNDP, a PET radiotracer for imaging sEH, was evaluated through quantitative PET imaging in the baboon brain, radiometabolite analysis, and radiation dosimetry estimate. METHODS: Baboon [(18)F]FNDP dynamic PET studies were performed at baseline and with blocking doses of the selective sEH inhibitor AR-9281 to evaluate sEH binding specificity. Radiometabolites of [(18)F]FNDP in mice and baboons were measured by high-performance liquid chromatography. Regional brain distribution volume (V(T)) of [(18)F]FNDP was computed from PET using radiometabolite-corrected arterial input functions. Full body distribution of [(18)F]FNDP was studied in CD-1 mice, and the human effective dose was estimated using OLINDA/EXM software. RESULTS: [(18)F]FNDP exhibited high and rapid brain uptake in baboons. AR-9281 blocked [(18)F]FNDP uptake dose-dependently with a baseline V(T) of 10.9 ± 2.4 mL/mL and a high-dose blocking V(T) of 1.0 ± 0.09 mL/mL, indicating substantial binding specificity (91.70 ± 1.74%). The V(ND) was estimated as 0.865 ± 0.066 mL/mL. The estimated occupancy values of AR-9281 were 99.2 ± 1.1% for 1 mg/kg, 88.6 ± 1.3% for 0.1 mg/kg, and 33.8 ± 3.8% for 0.02 mg/kg. Murine biodistribution of [(18)F]FNDP enabled an effective dose estimate for humans (0.032 mSv/MBq). [(18)F]FNDP forms hydrophilic radiometabolites in murine and non-human primate plasma. However, only minute amounts of the radiometabolites entered the animal brain (< 2% in mice). CONCLUSIONS: [(18)F]FNDP is a highly sEH-specific radiotracer that is suitable for quantitative PET imaging in the baboon brain. [(18)F]FNDP holds promise for translation to human subjects. Springer Berlin Heidelberg 2020-06-22 /pmc/articles/PMC7310027/ /pubmed/32572592 http://dx.doi.org/10.1186/s13550-020-00657-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Du, Yong Minn, Il Foss, Catherine Lesniak, Wojciech G. Hu, Feng Dannals, Robert F. Pomper, Martin G. Horti, Andrew G. PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title | PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title_full | PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title_fullStr | PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title_full_unstemmed | PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title_short | PET imaging of soluble epoxide hydrolase in non-human primate brain with [(18)F]FNDP |
title_sort | pet imaging of soluble epoxide hydrolase in non-human primate brain with [(18)f]fndp |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310027/ https://www.ncbi.nlm.nih.gov/pubmed/32572592 http://dx.doi.org/10.1186/s13550-020-00657-7 |
work_keys_str_mv | AT duyong petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT minnil petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT fosscatherine petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT lesniakwojciechg petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT hufeng petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT dannalsrobertf petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT pompermarting petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp AT hortiandrewg petimagingofsolubleepoxidehydrolaseinnonhumanprimatebrainwith18ffndp |